Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Huggins

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Biochemistry|October 23, 1990
Effects of cyclic GMP on the secondary structure of cyclic GMP dependent protein kinase and analysis of the enzyme's amino-terminal domain by far-ultraviolet circular dichroismW Landgraf, F Hofmann, J T Pelton, et al.
Biochemical Society Transactions|April 1, 1991
Secondary structure and conformational changes associated with substrate-binding and the N-terminus in cyclic GMP-dependent protein kinaseJ P Huggins, W Landgraf, F Hofmann, et al.
Developmental Medicine and Child Neurology|April 1, 1978
A modular seating system for cerebral-palsied childrenE Trefler, S Hanks, P Huggins, et al.
Peptides|January 1, 1994
The receptors for endothelins and their analogues in SK-N-MC neuroblastoma cellsJ P Huggins, J T Pelton, P L van Giersbergen
Biochemistry|October 1, 1991
1H NMR and circular dichroism studies of the N-terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipperR A Atkinson, V Saudek, J P Huggins, et al.
Lancet (London, England)|September 15, 2009
An academia-industry partnershipDavid Gillen, Joanna Hahn, Annabel Hinde, et al.
British Journal of Pharmacology|February 1, 1991
Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aortaS Topouzis, J P Huggins, J T Pelton, et al.
Journal of Medicinal Chemistry|July 25, 2003
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcersM Jonathan Fray, Roger P Dickinson, John P Huggins, et al.
Pain|June 26, 2012
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the kneeJohn P Huggins, Trevor S Smart, Stephen Langman, et al.
British Journal of Pharmacology|December 1, 1995
Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPSE Butt, D Pöhler, H G Genieser, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Biochemistry|October 23, 1990
Effects of cyclic GMP on the secondary structure of cyclic GMP dependent protein kinase and analysis of the enzyme's amino-terminal domain by far-ultraviolet circular dichroismW Landgraf, F Hofmann, J T Pelton, et al.
Biochemical Society Transactions|April 1, 1991
Secondary structure and conformational changes associated with substrate-binding and the N-terminus in cyclic GMP-dependent protein kinaseJ P Huggins, W Landgraf, F Hofmann, et al.
Developmental Medicine and Child Neurology|April 1, 1978
A modular seating system for cerebral-palsied childrenE Trefler, S Hanks, P Huggins, et al.
Peptides|January 1, 1994
The receptors for endothelins and their analogues in SK-N-MC neuroblastoma cellsJ P Huggins, J T Pelton, P L van Giersbergen
Biochemistry|October 1, 1991
1H NMR and circular dichroism studies of the N-terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipperR A Atkinson, V Saudek, J P Huggins, et al.
Lancet (London, England)|September 15, 2009
An academia-industry partnershipDavid Gillen, Joanna Hahn, Annabel Hinde, et al.
British Journal of Pharmacology|February 1, 1991
Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aortaS Topouzis, J P Huggins, J T Pelton, et al.
Journal of Medicinal Chemistry|July 25, 2003
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcersM Jonathan Fray, Roger P Dickinson, John P Huggins, et al.
Pain|June 26, 2012
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the kneeJohn P Huggins, Trevor S Smart, Stephen Langman, et al.
British Journal of Pharmacology|December 1, 1995
Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPSE Butt, D Pöhler, H G Genieser, et al.
Pageof 6